Seventy-nine (61.2%) of them had mild anemia (Hb 9.0–10.9 g/dl), 48 (37.2%) had moderate anemia (Hb 7.0–8.9 g/dl) whilst 2 (1.6%) had severe anemia (Hb <7.0 g/dl). Here, GSTM1 is linked to anemia.